• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名肝细胞癌患者门静脉及其肝内分支弥漫性摄取¹⁸F-FDG的¹⁸F-FDG PET/CT筛查研究

A (18)F-FDG PET/CT Screening Study of a Hepatocellular Carcinoma Patient with Diffuse (18)F-FDG Uptake into the Portal Vein and its Intrahepatic Branches.

作者信息

Koroglu Reyhan, Koksal Ismail, Gezer Fatma, Kahraman Aysegul, Kekilli Ersoy

机构信息

Department of Nuclear Medicine, Karabuk University, Karabuk, Turkey.

Department of Nuclear Medicine, Inonu University, Turgut Ozal Medical Center, Malatya, Turkey.

出版信息

World J Nucl Med. 2016 Jan-Apr;15(1):68-70. doi: 10.4103/1450-1147.167590.

DOI:10.4103/1450-1147.167590
PMID:26912985
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4729021/
Abstract

Major vascular invasion is one of the worst prognostic factors of hepatocellular carcinoma (HCC). Fludeoxyglucose F 18 ((18) F-FDG) positron emission tomography/computed tomography (PET/CT) method is succesfully being used in HCC patients for the detection of particularly long-distance metastasis. Major vascular invasion is shown by radiological methods [particularly dynamic CT and/or magnetic resonance imaging (MRI)]. A male patient aged 60 years was diagnosed with HCC, according to biopsy after the detection of a mass in the liver. His medical examinations that were performed for the evaluation in terms of liver transplantation were dynamic CT and dynamic MRI; invasion in the intrahepatic branches of the portal vein and in main portal vein was also detected. PET/CT was performed to investigate the distant metastases. Moreover, diffuse (18) F-FDG uptake in the intrahepatic branches of the portal vein and in the main portal vein was observed.

摘要

大血管侵犯是肝细胞癌(HCC)最糟糕的预后因素之一。氟脱氧葡萄糖F 18((18)F-FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)方法已成功应用于HCC患者,用于检测特别是远距离转移。大血管侵犯通过放射学方法(特别是动态CT和/或磁共振成像(MRI))显示。一名60岁男性患者在肝脏发现肿块后经活检确诊为HCC。为评估肝移植进行的医学检查是动态CT和动态MRI;还检测到门静脉肝内分支和主门静脉有侵犯。进行PET/CT以调查远处转移。此外,观察到门静脉肝内分支和主门静脉有弥漫性(18)F-FDG摄取。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3485/4729021/eb6041e7ea9e/WJNM-15-68-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3485/4729021/b87d2484a330/WJNM-15-68-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3485/4729021/eb6041e7ea9e/WJNM-15-68-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3485/4729021/b87d2484a330/WJNM-15-68-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3485/4729021/eb6041e7ea9e/WJNM-15-68-g002.jpg

相似文献

1
A (18)F-FDG PET/CT Screening Study of a Hepatocellular Carcinoma Patient with Diffuse (18)F-FDG Uptake into the Portal Vein and its Intrahepatic Branches.一名肝细胞癌患者门静脉及其肝内分支弥漫性摄取¹⁸F-FDG的¹⁸F-FDG PET/CT筛查研究
World J Nucl Med. 2016 Jan-Apr;15(1):68-70. doi: 10.4103/1450-1147.167590.
2
FDG-Avid Portal Vein Tumor Thrombosis from Hepatocellular Carcinoma in Contrast-Enhanced FDG PET/CT.增强型FDG PET/CT检查中肝细胞癌所致的FDG摄取阳性门静脉肿瘤血栓形成
Asia Ocean J Nucl Med Biol. 2015 Winter;3(1):10-7.
3
Efficacy of contrast-enhanced FDG PET/CT in patients awaiting liver transplantation with rising alpha-fetoprotein after bridge therapy of hepatocellular carcinoma.对比增强 FDG PET/CT 在桥接治疗肝细胞癌后甲胎蛋白升高的肝移植患者中的疗效。
Eur Radiol. 2018 Dec;28(12):5356-5367. doi: 10.1007/s00330-018-5425-z. Epub 2018 Jun 12.
4
A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma.18F-FDG和11C-醋酸盐PET/CT用于检测原发性和转移性肝细胞癌的前瞻性评估。
J Nucl Med. 2008 Dec;49(12):1912-21. doi: 10.2967/jnumed.108.055087. Epub 2008 Nov 7.
5
Predictive Value of 18F-FDG PET/CT for Vascular Invasion in Patients With Hepatocellular Carcinoma Before Liver Transplantation.18F-FDG PET/CT 对肝癌患者肝移植前血管侵犯的预测价值。
Clin Nucl Med. 2017 Apr;42(4):e183-e187. doi: 10.1097/RLU.0000000000001545.
6
Value of F-FDG PET/CT in the diagnosis of portal vein tumor thrombus in patients with hepatocellular carcinoma.F-FDG PET/CT 在肝细胞癌患者门静脉癌栓诊断中的价值。
Abdom Radiol (NY). 2019 Jul;44(7):2430-2435. doi: 10.1007/s00261-019-01997-2.
7
Usefulness 18F-FDG positron emission tomography/computed tomography for detecting recurrence of hepatocellular carcinoma in posttransplant patients.18F-FDG 正电子发射断层扫描/计算机断层扫描在移植后患者肝癌复发中的应用价值。
Liver Transpl. 2010 Jun;16(6):767-72. doi: 10.1002/lt.22069.
8
Diagnostic value of combining ¹¹C-choline and ¹⁸F-FDG PET/CT in hepatocellular carcinoma.¹¹C-胆碱与¹⁸F-FDG PET/CT联合应用在肝细胞癌中的诊断价值
Eur J Nucl Med Mol Imaging. 2016 May;43(5):852-859. doi: 10.1007/s00259-015-3241-0. Epub 2015 Nov 18.
9
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.
10
Role of ¹⁸F-FDG PET CT as an independent prognostic indicator in patients with hepatocellular carcinoma.¹⁸F-FDG PET CT作为肝细胞癌患者独立预后指标的作用。
Nucl Med Commun. 2013 Aug;34(8):749-57. doi: 10.1097/MNM.0b013e3283622eef.

引用本文的文献

1
Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases.肝脏:正常实质及疾病中的葡萄糖代谢与18F-氟脱氧葡萄糖PET表现
Am J Nucl Med Mol Imaging. 2021 Aug 15;11(4):233-249. eCollection 2021.

本文引用的文献

1
Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy.肝癌切除术治疗的放射预后因子。
Hepatobiliary Pancreat Dis Int. 2012 Dec 15;11(6):612-7. doi: 10.1016/s1499-3872(12)60232-x.
2
Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?正电子发射断层扫描(PET)用双重示踪剂[11C]乙酸盐和[18F]氟脱氧葡萄糖能否预测肝细胞癌中的微血管侵犯?
Liver Transpl. 2011 Oct;17(10):1218-25. doi: 10.1002/lt.22362.
3
The potential use of 2-[¹⁸F]fluoro-2-deoxy-D-galactose as a PET/CT tracer for detection of hepatocellular carcinoma.
2-[¹⁸F]氟-2-脱氧-D-半乳糖作为 PET/CT 示踪剂用于肝细胞癌检测的潜在用途。
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1723-31. doi: 10.1007/s00259-011-1831-z. Epub 2011 May 7.
4
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.2008 年全球癌症负担估计值:GLOBOCAN 2008。
Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.
5
FDG positron emission tomography/computed tomography for the detection of extrahepatic metastases from hepatocellular carcinoma.正电子发射断层扫描/计算机断层扫描在肝细胞癌肝外转移检测中的应用。
Hepatol Res. 2009 Feb;39(2):134-42. doi: 10.1111/j.1872-034X.2008.00416.x.
6
Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.肝细胞癌患者的微血管侵犯及其可预测的临床病理因素。
Ann Surg Oncol. 2008 May;15(5):1375-82. doi: 10.1245/s10434-008-9846-9. Epub 2008 Mar 7.
7
Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma.双示踪剂PET/CT成像在转移性肝细胞癌评估中的应用
J Nucl Med. 2007 Jun;48(6):902-9. doi: 10.2967/jnumed.106.036673. Epub 2007 May 15.
8
Small nodule detection in cirrhotic livers: evaluation with US, spiral CT, and MRI and correlation with pathologic examination of explanted liver.肝硬化肝脏中小结节的检测:超声、螺旋CT和MRI评估及其与移植肝病理检查的相关性
J Comput Assist Tomogr. 2001 May-Jun;25(3):327-36. doi: 10.1097/00004728-200105000-00001.
9
Prognosis of hepatocellular carcinoma: the BCLC staging classification.肝细胞癌的预后:BCLC分期分类
Semin Liver Dis. 1999;19(3):329-38. doi: 10.1055/s-2007-1007122.